Plasmacytoid Dendritic Cells Play a Role for Effective Innate Immune Responses during Chlamydia pneumoniae Infection in Mice

Plasmacytoid dendritic cells (pDCs) are known for their robust antiviral response and their pro-tolerance effects towards allergic diseases and tissue engraftments. However, little is known about the role pDCs may play during a bacterial infection, including pulmonary Chlamydia pneumoniae (CP). In this study, we investigated the role of pDCs during pulmonary CP infection. Our results revealed that depletion of pDCs during acute CP infection in mice results in delayed and reduced lung inflammation, with an early delay in cellular recruitment and significant reduction in early cytokine production in the lungs. This was followed by impaired and delayed bacterial clearance from the lungs which then resulted in a severe and prolonged chronic inflammation and iBALT like structures containing large numbers of B and T cells in these animals. We also observed that increasing the pDC numbers in the lung by FLT3L treatment experimentally results in greater lung inflammation during acute CP infection. In contrast to these results, restimulation of T-cells in the draining lymph nodes of pDC-depleted mice induced greater amounts of proinflammatory cytokines than we observed in control mice. These results suggest that pDCs in the lung may provide critical proinflammatory innate immune responses in response to CP infection, but are suppressive towards adaptive immune responses in the lymph node. Thus pDCs in the lung and the draining lymph node appear to have different roles and phenotypes during acute CP infection and may play a role in host immune responses.

[1]  E. Butcher,et al.  Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. , 2012, Immunity.

[2]  Katsuaki Sato,et al.  Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. , 2011, Immunity.

[3]  H. Hammad,et al.  Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen‐presenting potential of plasmacytoid DCs , 2011, Journal of leukocyte biology.

[4]  M. Wick,et al.  Plasmacytoid dendritic cells mature independently of MyD88 and IFN-αβR in response to Listeria and stimulate CD8 T cells. , 2011, Immunology letters.

[5]  Moshe Arditi,et al.  Caspase-1 Dependent IL-1β Secretion Is Critical for Host Defense in a Mouse Model of Chlamydia pneumoniae Lung Infection , 2011, PloS one.

[6]  R. Alsabeh,et al.  Chlamydia pneumoniae Infection Induced Allergic Airway Sensitization Is Controlled by Regulatory T-Cells and Plasmacytoid Dendritic Cells , 2011, PloS one.

[7]  J. Rodriguez-Barbosa,et al.  Flt3L‐mobilized dendritic cells bearing H2‐Kbm1 apoptotic cells do not induce cross‐tolerance to CD8+ T cells across a class I MHC mismatched barrier , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  S. Weiss,et al.  Production of IFN-β during Listeria monocytogenes Infection Is Restricted to Monocyte/Macrophage Lineage , 2011, PloS one.

[9]  E. Engleman,et al.  Plasmacytoid Dendritic Cell Dichotomy: Identification of IFN-α Producing Cells as a Phenotypically and Functionally Distinct Subset , 2011, The Journal of Immunology.

[10]  M. Colonna,et al.  Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. , 2010, Immunity.

[11]  S. Phipps,et al.  Regulation of inducible BALT formation and contribution to immunity and pathology , 2010, Mucosal Immunology.

[12]  Shuang Chen,et al.  Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses. , 2010, American journal of respiratory cell and molecular biology.

[13]  B. Chambers,et al.  Plasmacytoid dendritic cell‐induced migration and activation of NK cells in vivo , 2010, European journal of immunology.

[14]  L. Boon,et al.  Cutting Edge: Pulmonary Legionella pneumophila Is Controlled by Plasmacytoid Dendritic Cells but Not Type I IFN , 2010, The Journal of Immunology.

[15]  D. Underhill,et al.  The NOD/RIP2 Pathway Is Essential for Host Defenses Against Chlamydophila pneumoniae Lung Infection , 2009, PLoS pathogens.

[16]  P. Shah,et al.  TLR/MyD88 and Liver X Receptor α Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis1 , 2008, The Journal of Immunology.

[17]  N. Escriou,et al.  Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. , 2008, Blood.

[18]  A. Nel,et al.  Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization. , 2008, The Journal of allergy and clinical immunology.

[19]  Nicholas J Alp,et al.  Role of Chlamydia pneumoniae in atherosclerosis. , 2008, Clinical science.

[20]  E. R. Sutherland,et al.  Asthma and atypical bacterial infection. , 2007, Chest.

[21]  B. Baban,et al.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. , 2007, The Journal of clinical investigation.

[22]  G. Belz,et al.  A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection , 2007, European journal of immunology.

[23]  Taku Sato,et al.  Interleukin 15–dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation , 2006, Nature Immunology.

[24]  A. Rothfuchs,et al.  STAT1 Regulates IFN-αβ- and IFN-γ-Dependent Control of Infection with Chlamydia pneumoniae by Nonhemopoietic Cells1 , 2006, The Journal of Immunology.

[25]  F. Fend,et al.  Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae , 2006, European journal of immunology.

[26]  R. Alsabeh,et al.  MyD88 Is Pivotal for the Early Inflammatory Response and Subsequent Bacterial Clearance and Survival in a Mouse Model of Chlamydia pneumoniae Pneumonia* , 2005, Journal of Biological Chemistry.

[27]  G. Trinchieri,et al.  The Reciprocal Interaction of NK Cells with Plasmacytoid or Myeloid Dendritic Cells Profoundly Affects Innate Resistance Functions1 , 2005, The Journal of Immunology.

[28]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[29]  H. Hammad,et al.  Essential Role of Lung Plasmacytoid Dendritic Cells in Preventing Asthmatic Reactions to Harmless Inhaled Antigen , 2004, The Journal of experimental medicine.

[30]  M. Mihm,et al.  Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. , 2000, Cancer research.

[31]  J. Grayston.  Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. , 2000, The Journal of infectious diseases.

[32]  V. Levitsky,et al.  Regulation and Role of IFN-γ in the Innate Resistance to Infection with Chlamydia pneumoniae1 , 2000, The Journal of Immunology.

[33]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Prendergast,et al.  Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. , 2012, The Journal of infectious diseases.

[35]  Hubertus Hochrein,et al.  Dendritic cell subsets and toll-like receptors. , 2008, Handbook of experimental pharmacology.

[36]  R. Schreiber,et al.  Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation , 2006 .

[37]  A. Rothfuchs,et al.  STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells. , 2006, Journal of immunology.

[38]  V. Levitsky,et al.  Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. , 2000, Journal of immunology.

[39]  M. Drumm.  in vivo. , 1999 .